Home / People / Dr Daniel Jenny
Jenny Daniel

Dr Daniel Jenny, LL.M.

Partner

CMS von Erlach Poncet Ltd.
Dreikönigstrasse 7
P.O. Box
8022 Zurich
Switzerland
Languages French, English, German

Daniel Jenny specialises in M&A transactions, capital markets, corporate restructurings, general corporate and commercial matters (e.g. joint ventures, shareholders' agreements). He is active in various sectors, including private equity, TMC and Life Science & Healthcare.

Besides his experience in a broad range of international and national M&A transactions (both sell and buy side), including auction processes and carve-out transactions, Daniel Jenny is a recognised expert in corporate governance, in particular concerning questions on directors' liability. His expertise also includes corporate litigation: He often represents clients in directors' liability lawsuits and post M&A disputes or other corporate litigation (e.g. special audit). Among his clients are listed companies and private companies (both small and medium-sized, private equity firms) as well as individuals (in particular investors and board members).

After his traineeship with CMS and his clerkship with the District Court of Zurich, Daniel Jenny was admitted to the bar in 2007 and has since been working as a lawyer with CMS. He gained additional work experience as an international associate in a New York-based law firm and as legal counsel in an industrial multinational (Hilti AG). Daniel Jenny authored various legal publications. His thesis "Means of Defence of Board Members in Directors' Liability Lawsuits" approved by the University of Zurich in 2012 (summa cum laude) was awarded with the Professor Walther Hug prize.

more less

Sources describe Daniel Jenny as "calm under pressure, business-oriented, pragmatic and efficient."

Chambers and Partners, Corporate/M&A - Switzerland, Global, 2020

"Strong communication, creative and open to involve other disciplines."

IFLR1000, Financial and corporate, Switzerland, 2019

Daniel Jenny is able to think through complex questions very quickly and give to the point, direct answers.

Chambers and Partners, Corporate/M&A, Switzerland, 2019

Daniel Jenny is recommended by clients as "rising star" in the area "Commercial, Corporate and M&A".

The Legal 500, Commercial, corporate and M&A, Switzerland, 2018

Relevant experience

  • Advised EMS-Group on the sale of EMS-PATVAG (s.r.o.)
  • Advised ABB on the acquisition of Cassantec
  • Advised Showa Denko on the acquisition of the ILAG Group from Helvetica Capital (with City-Yuwa Partners, Tokyo)
  • Advised Bruker Switzerland AG on the acquisition of PMOD Technologies LLC
  • Advised capiton/CymbiQ Group AG on the acquisition of Koch IT
  • Advised AEW on the acquisition of a participation in evpass SA (Joint Venture)
  • Advised capiton/CymbiQ Group on the acquisition of anovis it-services and trading gmbh
  • Advised the Koller family on the sale of the Hoegger group to Provisur Technologies
  • Advised Nextclinics on the acquisition of IVF-Zentren Prof. Zech (a group of clinics for the reproductive medicine)
  • Advised shareholder 7-Industries B.V. relating to the increase of its participation as new anchor shareholder of Sensirion Holding AG in connection with the Sensirion-IPO
  • Advised LifeWatch on the Competing Public Takeovers from BioTelemetry and AEVIS Victoria
  • Advised Rieter on the acquisition of the SSM division from Schweiter
  • Advised Sunrise on the sale of Swiss Towers AG
  • Advised Merbag on the acquisition of Mercedes-Benz Milano from Mercedes-Benz Italia (Daimler Group)
  • Advised Heraeus on the acquisition of Argor-Heraeus
  • Counsel to independent board members of Sika in a directors’ liability action regarding the contemplated Saint-Gobain takeover
  • Advised Schaeffler regarding all legal aspects related to the sale of its fine-blanking business to the Swiss Guentensperger Group
  • Advised Synergie on the Swiss aspects of the legal structuring and establishment of the partnership with Cavallo Suisse Invest AG
  • Advised Aurelius on the acquisition of the trade operations of the listed Swiss Valora Group
  • Advised Alstom on the sale of parts of its gas turbine business to Ansaldo Energia
  • Advised majority shareholders of the soccer team FC Wil on the sale of their share to a Turkish multinational corporation
  • Advised Sonic Healthcare in acquisition of Swiss laboratory group Medisupport
  • Advised Gemalto on the acquisition of Trüb's secure document business
  • Counsel to former board members of SAirGroup in directors' liability action
  • Advised Ametek on the acquisition of the Teseq Group
  • Advised LCP Europe Limited (belonging to the Alexander Forbes Group) on the sale of LCP Libera AG
  • Advised on the sale of Colibrys SA in a multi-seller transaction
more less

Education

  • 2012 Doktorat, Dr. iur., summa cum laude, Universität Zürich, Prof. Walther Hug Preis
  • 2010 Master of Laws, LL.M ,New York University School of Law, Half Tuition Dean's Graduate Award
  • 2007 Anwaltspatent
  • 2004 Visiting Scholar, Max Planck Institut für ausländisches und internationales Privatrecht, Hamburg
  • 2003 Rechtsstudium, lic. iur., magna cum laude, Universität Zürich
more less

Memberships

  • Zürcher Anwaltsverband (ZAV)
  • Schweizerischer Anwaltsverband (SAV)
  • SECA
more less

Lectures list

  • Share Purchase Agreements: Latest Developments and Trends, Finanz und Wirtschaft Forum, Corporate Finance, Mergers & Acquisitions 2019, Business Transformation – the new Normal, 27 August 2019
  • Role of Board Members in M&A Transactions, Finanz und Wirtschaft Forum, Corporate Finance, Mergers & Acquisitions 2018, Shape your Business, 11 September 2018
  • Neue Finanzierungsformen: Crowdfunding und Initial Coin Offering (ICO), CMS M&A Breakfast, 15. Mai 2018
  • Unternehmenstransaktionen im rechtlichen und ökonomischen Kontext, Arten und Ablauf einer M&A Transaktion aus juristischer Sicht, Gastvorlesung an der HSG vom 25. April 2018
  • Abwehrmöglichkeiten von Verwaltungsratsmitgliedern gegen den Vorwurf der Pflichtverletzung, 9. EIZ-Tagung zur Verantwortlichkeit im Unternehmensrecht, 29. August 2017
  • Post-Closing M&A Disputes │ Rechtliche Aspekte, CMS M&A Breakfast, 10. Mai 2016
  • Überblick und Neues zur Business Judgment Rule, Aktuelle Entwicklungen in der aktienrechtlichen Verantwortlichkeit, CMS Lunch, 14. März 2013
  • Abwehrmöglichkeiten von Verwaltungsratsmitgliedern in Verantwortlichkeitsprozessen, Eine prozessuale Betrachtung, Institut für Rechtswissenschaft und Rechtspraxis, Universität St. Gallen, ZPO – Fallstricke und Chancen, 7. März 2013
more less
18/11/2015
CMS ad­vises Aure­li­us on the ac­quis­i­tion of the trade...
08/06/2017
D&O li­ab­il­ity and in­sur­ance
25/02/2016
Syn­er­gie ad­vised by CMS on part­ner­ship with em­ploy­ment...

Feed

Show only
27 Nov 19
CMS ad­vised EMS-Group on the sale of EMS-PATVAG (s.r.o.)
20 Sep 19
D&O Li­ab­il­ity and In­sur­ance – Part 2: Ob­tain­ing ad­equate In­sur­ance...
Au­thors: Dr Daniel Jenny / Dr Clem­ens von Zedtwitz   In­tro­duc­tion The max­im that "Any­thing that can go wrong will go wrong" is es­pe­cially true of busi­ness where mis­takes can nev­er be fully avoided,...
15 Nov 19
CMS ad­vised ABB on the ac­quis­i­tion of Cas­santec Ltd
20 Sep 19
D&O Li­ab­il­ity and In­sur­ance – Part 1: Basis of Li­ab­il­ity and Avoid­ance...
Au­thors: Dr Daniel Jenny / Dr Clem­ens von Zedtwitz In­tro­duc­tion The max­im "Any­thing that can go wrong will go wrong" is es­pe­cially true of busi­ness where mis­takes can nev­er be fully avoided. Board mem­bers...
15 Aug 19
Switzer­land re­vises trans­par­ency ob­lig­a­tions
Part 2: Swiss par­lia­ment in­tro­duces crim­in­al fines...
14 Aug 19
Switzer­land re­vises trans­par­ency ob­lig­a­tions – Part 2: Swiss par­lia­ment...
Switzer­land re­vises trans­par­ency ob­lig­a­tions On 21 June 2019, the Swiss par­lia­ment passed a law that im­ple­men­ted the re­com­mend­a­tions of the Glob­al For­um on Trans­par­ency and Ex­change of In­form­a­tion for...
30 Jul 19
Switzer­land re­vises trans­par­ency ob­lig­a­tions
Part 1: Swiss Par­lia­ment bids farewell to bear­er shares
30 Jul 19
Switzer­land re­vises trans­par­ency ob­lig­a­tions – Part 1: Swiss Par­lia­ment...
Switzer­land says good-bye to bear­er shares On 21 June 2019, the Swiss par­lia­ment passed a law that im­ple­men­ted the re­com­mend­a­tions of the Glob­al For­um on Trans­par­ency and Ex­change of In­form­a­tion for Tax...
11 Jul 19
City-Yuwa Part­ners and CMS ad­vised Showa Den­ko on the...
07 Mar 18
Farewell to bear­er shares and in­tro­duc­tion of crim­in­al sanc­tions for...
On 17 Janu­ary 2018, the Swiss Fed­er­al Coun­cil launched the con­sulta­tion (Vernehm­las­sung) on the im­ple­ment­a­tion of the re­com­mend­a­tions of the Glob­al For­um on Trans­par­ency and Ex­change of In­form­a­tion for...
08 Jul 19
CMS ad­vises Bruker on the ac­quis­i­tion of PMOD Tech­no­lo­gies...
21 May 19
CMS ad­vises capiton/Cym­biQ on the ac­quis­i­tion of Koch...